5/18
Meredith Mann
meredith.mann@pennmedicine.upenn.edu
Getting PrEP in the hands of high-risk communities remains a challenge; Penn researchers and practitioners are finding ways to reduce barriers and investigate new forms of the drug.
Over two days, nearly two dozen female STEM role models at Penn welcomed more than 100 high school students and teachers to campus as part of the Girls Advancing in STEM (GAINS) Initiative Conference on campus.
That’s the question Allyson Mackey and Dylan Tisdall hope to answer, through a new grant from an NIH initiative focused on addiction research.
The findings may inform use of the recent FDA-approved drug rituximab to better treat patients with pemphigus, a rare chronic autoimmune condition.
Alongside Nursing Dean Antonia M. Villarruel, Penn President Amy Gutmann and PIK Professor Jonathan Moreno discussed their new book “Everybody Wants to Go to Heaven but Nobody Wants to Die” at the Smilow Center for Translational Research.
An FDA-approved drug called exendin-4 decreased voluntary oxycodone taking and drug-seeking behavior during withdrawal in rats without reducing the relief the opioid provided.
A new Penn Medicine study shows the risks of complications and readmissions may be lower than the risks associated with lifelong obesity.
Penn Medicine’s Florencia Greer Polite wants doctors to take a more proactive approach to conversations with their patients about consent and sexual abuse.
One of the nation’s highest honors in biomedicine, members are elected by their peers for accomplishments and contributions to the advancement of the medical sciences, health care, and public health.
All new students face challenges in the transition to college, but for first-generation, low-income (FGLI) students, it’s a whole new world. Providing a community for these students helps counter feelings of isolation and the “impostor” syndrome that FGLI students may experience.
Meredith Mann
meredith.mann@pennmedicine.upenn.edu
Penn Medicine’s transfer command center gets patients from affiliated hospitals and hospitals outside Philadelphia to specialized care that can save lives, with comments from CEO Kevin Mahoney.
FULL STORY →
Penn Medicine is phasing out the anesthesia desflurane at four of its six hospitals to eliminate harmful greenhouse gases, with remarks from Greg Evans.
FULL STORY →
Casey Jo Humbyrd and Josh Baxter of the Perelman School of Medicine and colleagues will track data from running the Broad Street Run to understand how a healthy Achilles tendon functions.
FULL STORY →
Bruce Brod of the Perelman School of Medicine says that prolonged or overuse of topical steroids can cause rosacea, skin thinning, stretch marks, and an extreme and debilitating withdrawal.
FULL STORY →
Shoshana Aronowitz of the School of Nursing and Ashish Thakrar of the Perelman School of Medicine comment on the lack of specificity in Philadelphia’s plan to remove drug users from Kensington and on the current state of drug treatment in the city.
FULL STORY →
A profile highlights Maria Wright of Penn Medicine Lancaster General Health, from her volunteer work connecting people with service dogs to her cancer diagnosis and her own journey applying for a service dog.
FULL STORY →